Login Join us
Benefits Strategy

PCSK-9 Inhibitors: Next-Level Cholesterol Management

Although approximately 73.5 million people in the U.S. have high cholesterol, not all are candidates for treatment with PCSK-9 inhibitors.

icon_featured_hand

January 10, 2019

TABLE OF CONTENTS

  1. Who Should Take PCSK-9 Inhibitors?
  2. PCSK-9 Inhibitors: Game Changers for Some Patients
  3. PCSK-9 Inhibitors are Safe, Effective, Injectable Specialty Medications
  4. Assessing the Impact
  5. What Employers Can Do